Single Nucleotide Polymorphism (SNP) Genotyping Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Single Nucleotide Polymorphism (SNP) Genotyping Market?
The rise in chronic conditions is anticipated to fuel the expansion of the single nucleotide polymorphism (SNP) genotyping market. Chronic conditions are lasting ailments that require consistent medical attention and may limit daily activities. Single nucleotide polymorphism (SNP) genotyping plays a critical role in detecting genetic predispositions and facilitating personalised medicine given the escalating prevalence of chronic illnesses. For instance, data from the Australian Institute of Health and Welfare, a governmental organization in Australia, revealed that the mortality rate associated with chronic conditions increased from 459 deaths per 100,000 population in 2021 to 490 deaths per 100,000 population in 2022 as of June 2024. Consequently, the mounting pressure of chronic conditions propels the growth of the single nucleotide polymorphism (SNP) genotyping systems market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12569&type=smp
How Will the Growth Rate of theSingle Nucleotide Polymorphism (SNP) Genotyping Market Impact Industry Trends by 2034?
Recent years have seen an accelerated expansion of the single nucleotide polymorphism (SNP) genotyping market. The market, valued at $10.3 billion in 2024, is predicted to escalate to $12.37 billion in 2025, a transformative compound annual growth rate (CAGR) of 20.1%. The notable increase during the historical period is a result of factors such as heightened genomics research, a spike in genetic disorders, the expansion of personalized medicine, a burgeoning pharmaceutical sector, and increasing need for molecular diagnostics.
The market size for single nucleotide polymorphism (SNP) genotyping is projected to expand rapidly in the upcoming years, reaching a value of $24.95 billion in 2029 with a compound annual growth rate (CAGR) of 19.2%. This expected growth in the forecast period is due to factors such as increased use in disease research, a growing demand for accuracy in medicine, evolving biobanking initiatives, an uptick in genetic testing, and widespread use in agriculture aimed at improving crop yield. Key trends anticipated during this forecast period comprise a greater usage of next-generation sequencing (NGS), amplified demand for SNP genotyping within pharmacogenomics, the arrival of direct-to-consumer genetic testing, a shift towards automation, and the use of high-throughput genotyping platforms.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12569
What Are the Key Market Innovations in theSingle Nucleotide Polymorphism (SNP) Genotyping Market Over the Coming Years?
The rising trend of technology-oriented solutions is making a significant impact in the single nucleotide polymorphism (SNP) genotyping industry. To remain competitive in the market, primary players in the SNP genotyping industry are introducing innovative technology-based solutions. For example, in May 2022, Neogen Corporation, an American company offering solutions to sectors like agriculture, animal protein, food, and beverages, and Gencove, an American sequencing solutions company, jointly launched InfiniSEEK. As the first comprehensive genome and genotyping tool for cattle breeders, InfiniSEEK has demonstrated through rigorous validation that low-pass genome-wide sequencing ranks over 99% in concordance with deep whole-genome sequencing, delivering even greater clinical-grade precision in selected areas.
Who Are the Top Companies Driving Innovation and Growth in theSingle Nucleotide Polymorphism (SNP) Genotyping Market?
Major companies operating in the single nucleotide polymorphism (SNP) genotyping market include Thermo Fischer Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Single Nucleotide Polymorphism (SNP) Genotyping Market and Drive Its Revenue Growth?
The single nucleotide polymorphism (SNP) genotyping market covered in this report is segmented –
1) By Product: Consumables, Instruments, Services
2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies
3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications
Subsegments:
1) By Consumables: Reagents And Kits, DNA Probes, Microarrays
2) By Instruments: SNP Genotyping Platforms, Sequencers, PCR Machines
3) By Services: SNP Genotyping Services, Data Analysis Services, Consultation Services
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12569&type=smp
Which Regions Are Emerging as Leaders in the Single Nucleotide Polymorphism (SNP) Genotyping Market?
North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (SNP) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Single Nucleotide Polymorphism (SNP) Genotyping Maret 2025, By The Business Research Company:
Polypropylene Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/polypropylene-global-market-report
Poly-Vinyl Chloride Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/poly-vinyl-chloride-global-market-report
Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
